
Can a Cancer Therapy Win Without a Patent?
Send us Fan Mail Drug approval rewards a single patented product proven in large trials. Dr. Francisco Contreras of Oasis of Hope argues that this model leaves out personalized cell therapies and cheap natural compounds that no company will pay to test. We discuss why the FDA standard exists and asks whether government-funded studies should fill the gap to fund the evidence for products without a patent. A frank conversation about cancer, drugs, and alternative therapies. LinkedIn Company Website See More ChalkTalkJim Episodes













